Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07030153

Association of Genetic Variants With Myopia

Genetic Variants and Their Association With Myopia Risk, Progression, and Optimal Interventions in Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Beijing Visionly Plus Eye Hospital · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Accepted

Summary

This study aims to identify genetic factors linked to myopia, including those that influence a person's risk of developing it and how quickly it progresses (like changes in eye length). It will also examine how different treatments-such as low-dose atropine drops, orthokeratology lenses, specialized glasses, and increased outdoor time-interact with these genes. Finally, the research will develop a genetic risk score to help tailor personalized myopia prevention and treatment plans.

Conditions

Interventions

TypeNameDescription
GENETICOral swab DNA analyzed for myopia-related gene variantsBeyond detecting links between gene variants and myopia development, the testing analyzes how these variants influence treatment effectiveness. The aim is to enable early risk prediction and personalized treatment guidance for children through oral DNA testing.

Timeline

Start date
2025-07-01
Primary completion
2028-08-31
Completion
2028-12-31
First posted
2025-06-22
Last updated
2025-06-22

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07030153. Inclusion in this directory is not an endorsement.